1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. ACT Laboratories Acquires CDX Analytics

M&A Deal Summary

ACT Laboratories Acquires CDX Analytics

On September 28, 2022, ACT Laboratories acquired life science company CDX Analytics

Acquisition Highlights
  • This is ACT Laboratories’ 1st transaction in the Life Science sector.
  • This is ACT Laboratories’ 1st transaction in the United States.
  • This is ACT Laboratories’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2022-09-28
Target CDX Analytics
Sector Life Science
Buyer(s) ACT Laboratories
Deal Type Add-on Acquisition

Target

CDX Analytics

Salem, Massachusetts, United States
CDX Analytics is a premiere cannabis testing laboratory servicing both the Medical and Recreational Marijuana markets in the Commonwealth of Massachusetts. CDX Analytics is based in Salem, Massachusetts.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

ACT Laboratories

Lansing, Michigan, United States
Category Company
Sector Life Science
DESCRIPTION

ACT Laboratories provides critical lab testing services for cultivators, processors, dispensaries, and brands to satisfy state requirements for a broad spectrum of tests, including potency, terpene, pesticide, microbial. ACT Laboratories is based in Lansing, Michigan.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal